Campos-Rivera Paola Abril, Alfaro-Ponce Berenice, Ramírez-Pérez Michelle, Bernal-Serrano Daniel, Contreras-Loya David, Wirtz Veronika J
Tecnologico de Monterrey, The Institute for Obesity Research, Av. Eugenio Garza Sada 2501 Sur, Tecnológico, 64700, Monterrey N.L., Mexico; Tecnologico de Monterrey, Escuela de Gobierno y Transformación Pública, School of Government and Public Transformation, Av. Revolución 756, Nonoalco, Benito Juárez, 03700, Mexico City, Mexico.
Tecnologico de Monterrey, The Institute for Obesity Research, Av. Eugenio Garza Sada 2501 Sur, Tecnológico, 64700, Monterrey N.L., Mexico.
Soc Sci Med. 2025 Feb;366:117646. doi: 10.1016/j.socscimed.2024.117646. Epub 2024 Dec 27.
Social media can be a platform to spread misinformation and reinforce potentially harmful norms in the interest of commercial actors. There are norms related to obesity that commercial actors promote such as "obesity is an individual problem" and the "pharmaceuticalization of obesity". In this study, we assess the quality of information about semaglutide, and the descriptive norms related to its use as levers of commercial practices in social media. We carried out a content analysis of Spanish speaking TikTok videos published between January 2022 and November 2023. We used the DISCERN instrument to assess the quality of information and classified the social norms disseminated through the videos and the narrating voices. The overall quality of information was low, with a mean DISCERN score of 29.8 out of 75. Although healthcare professionals and professional communicators performed slightly better compared to other voices, critical aspects of good health communication were often lacking; 155 videos (71%) did not mention any risk related to the use of semaglutide and only 11.9% of videos mentioned one or more serious risks. In 85% of videos, obesity was depicted as an individual problem. About half of the videos normalized the use of semaglutide and 79% of videos promoted the pharmaceuticalization of obesity by mentioning losing weight as a benefit of using semaglutide but not mentioning the need to make lifestyle changes. The combination of poor-quality health information and the promotion of potentially harmful norms related to semaglutide use is a public health concern. Further research on the commercial determinants of health in the context of semaglutide use is needed, as well as actions to mitigate the risks of misinformation and harmful health-related norms.
社交媒体可能成为传播错误信息和强化潜在有害规范的平台,以满足商业行为者的利益。商业行为者宣扬一些与肥胖相关的规范,比如“肥胖是个人问题”以及“肥胖的药物化”。在本研究中,我们评估了关于司美格鲁肽的信息质量,以及在社交媒体中作为商业行为手段与其使用相关的描述性规范。我们对2022年1月至2023年11月期间发布的西班牙语TikTok视频进行了内容分析。我们使用DISCERN工具评估信息质量,并对通过视频和旁白传播的社会规范进行分类。信息的整体质量较低,DISCERN平均得分在75分中为29.8分。尽管医疗保健专业人员和专业传播者的表现略优于其他声音,但良好健康传播的关键方面往往缺失;155个视频(71%)未提及与使用司美格鲁肽相关的任何风险,只有11.9%的视频提到了一种或多种严重风险。在85%的视频中,肥胖被描述为个人问题。大约一半的视频将司美格鲁肽的使用常态化,79%的视频通过提及减肥是使用司美格鲁肽的好处但未提及改变生活方式的必要性来宣扬肥胖的药物化。低质量的健康信息与宣扬与司美格鲁肽使用相关的潜在有害规范相结合,是一个公共卫生问题。需要进一步研究司美格鲁肽使用背景下健康的商业决定因素,以及采取行动减轻错误信息和有害健康规范的风险。